Form 4: Aytu Biopharma CEO Receives Stock Grant
Insider Transaction (Form 4)
Joshua R. Disbrow, Chief Executive Officer and a Director of Aytu Biopharma, Inc, received 30,000 shares of common stock on July 28, 2026.
Summary
- Grant/award: acquired 30,000 Common Stock on July 28, 2026; holds 237,203 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joshua R. Disbrow — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Common Stock | 30,000 | — | — | 237,203 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (30,000 shares) |
Keywords
insider transaction, Form 4, AYTU, AYTU BIOPHARMA, INC, neutral, Joshua R. Disbrow
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.